SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001104659-17-041854
Filing Date
2017-06-27
Accepted
2017-06-27 17:21:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A a17-14996_3sc14d9a.htm SC 14D9/A 54725
  Complete submission text file 0001104659-17-041854.txt   56207
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filed by) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-89113 | Film No.: 17933127
SIC: 2834 Pharmaceutical Preparations